Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “United Kingdom”
Sponsor: Bayer
Hepatocellular Carcinoma
United States, Belgium, Canada, China, Finland +4 more
Sponsor: Celgene
Metastatic Castration-resistant Prostate Cancer
United States, Argentina, Australia, Austria, Brazil +21 more
Sponsor: Bristol-Myers Squibb
Hepatocellular Carcinoma (HCC)
United States, Australia, Chile, China, France +9 more
- Hydra Registry - UKRecruiting
Sponsor: Sahajanand Medical Technologies Limited
Aortic Valve Stenosis
United Kingdom
Sponsor: Bristol-Myers Squibb
Plaque Psoriasis
Argentina, Australia, Brazil, Canada, France +8 more
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Relapsed or Refractory Multiple Myeloma (RRMM)
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: Bristol-Myers Squibb
Relapsed/Refractory Non-Hodgkin Lymphoma
United States, Chile, China, France, Germany +10 more
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia
United States, Argentina, Australia, Brazil, Bulgaria +20 more
Sponsor: Inari Medical
Venous Thromboembolism · Deep Venous Thrombosis · Post-Thrombotic Syndrome
United States, Austria, Finland, Germany, Switzerland +1 more
Sponsor: Theradex
Leukemia, Myelomonocytic, Chronic
United States, United Kingdom
- A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab AloneActive Not Recruiting
Sponsor: Boehringer Ingelheim
Head and Neck Squamous Cell Carcinoma
United States, Australia, Brazil, Bulgaria, France +17 more
Sponsor: Bristol-Myers Squibb
Lung Cancer · Breast Cancer
United States, Australia, Canada, Chile, France +5 more
Sponsor: Cytokinetics
Heart Failure · Heart Failure With Reduced Ejection Fraction
United States, Canada, China, France, Germany +5 more
- A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).Active Not Recruiting
Sponsor: Cytokinetics
Pediatric · Symptomatic Obstructive Hypertrophic Cardiomyopathy
United States, Canada, Italy, Japan, Spain +1 more
- A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement InhibitorsActive Not Recruiting
Sponsor: Hoffmann-La Roche
Paroxysmal Nocturnal Hemoglobinuria
Argentina, Brazil, China, France, Germany +18 more
Sponsor: University of Ulster
Stroke
Italy, United Kingdom
- Product Surveillance RegistryRecruiting
Sponsor: Medtronic
Cardiac Rhythm Disorders · Urological Disorders · Neurological Disorders · Cardiovascular Disorders
United States, Argentina, Australia, Austria, Belgium +36 more
Sponsor: Hoffmann-La Roche
Dup15q Syndrome
United States, Spain, United Kingdom
- A Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerRecruiting
Sponsor: AstraZeneca
Metastatic Colorectal Cancer
United States, Australia, Canada, China, France +7 more
- A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated CardiomyopathyNot Yet Recruiting
Sponsor: Kardigan, Inc.
Symptomatic Genetic Dilated Cardiomyopathy (DCM)
United States, Belgium, Denmark, France, Hungary +6 more
Sponsor: Novo Nordisk A/S
Heart Failure
United Kingdom
Sponsor: Jaeb Center for Health Research
Inherited Retinal Degeneration · Retinitis Pigmentosa
United States, Australia, Belgium, Brazil, Canada +9 more
- A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell DiseaseRecruiting
Sponsor: Bristol-Myers Squibb
Anemia, Sickle Cell · Healthy Volunteers
United States, Canada, France, Italy, United Kingdom
- A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Early Breast Cancer
United States, Argentina, Australia, Austria, Belgium +15 more
- Mindfulness for Central Serous ChorioretinopathyNot Yet Recruiting
Sponsor: King's College Hospital NHS Trust
Central Serous Chorioretinopathy
United Kingdom